SCHEMBL2486964

SCHEMBL2486964

c1ccc(COc2ccccc2NC2CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.53
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ SGMS2 Q8NHU3 1/20 0.48
▸ HTR1A P08908 4/20 0.48
▸ SLC6A2 P23975 2/20 0.48
▸ SLC6A4 P31645 2/20 0.48
▸ SLC6A3 Q01959 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ APP P05067 1/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ LIPE Q05469 1/20 0.44
▸ MAPK8 P45983 1/20 0.43
▸ MAPK9 P45984 1/20 0.43
▸ ADRA1D P25100 1/20 0.43
▸ ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11099873 0.87 HTR6 (0.49) BRD4MEN1KMT2AALDH1A1DRD2
SCHEMBL21460278 0.84 SLC6A4 (0.53) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL28841156 0.82 BRD4 (0.43) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL23496440 0.75 BRD4 (0.58) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL31153242 0.75 BRD4 (0.58) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL28316872 0.75 BRD4 (0.63) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL1987283 0.75 BRD4 (0.58) BRD4MEN1KMT2AALDH1A1SGMS2
SCHEMBL8158080 0.75 APP (0.75) BRD4MEN1KMT2AALDH1A1SGMS2
Hydrochloric Acid SCHEMBL73561 0.74 HTR1A (0.46) HTR1ASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL9745109 0.74 BRD4 (0.57) BRD4SGMS2HTR1ATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 — — WO disclosed
EP-2379174-A1 PHARMACEUTICAL PRODUCT COMPRISING A P38 KINASE INHIBITOR AND A SECOND ACTIVE INGREDIENT AstraZeneca AB (SE) 2011-10-26 — — EP disclosed
WO-2010071583-A1 PHARMACEUTICAL PRODUCT COMPRISING A P38 KINASE INHIBITOR AND A SECOND ACTIVE INGREDIENT ASTRAZENECA AB (SE) 2010-06-24 — — WO disclosed
Send feedback